Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunovant, Inc. - Common Stock (NQ:IMVT)

14.72 -0.35 (-2.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunovant, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New... 
Via Benzinga
Immunovant: Q1 Earnings Insights
Immunovant (NASDAQ:IMVT) reported its Q1 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Immunovant beat estimated earnings... 
Via Benzinga
Immunovant To Start Pivotal Batoclimab Trials In Thyroid Eye Disease Later This Year
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
Via Benzinga
Immunovant: Q3 Earnings Insights
  Immunovant (NASDAQ:IMVT) reported its Q3 earnings results on Friday, February 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For June 8, 2022
Companies Reporting Before The Bell • Immunovant (NASDAQ:IMVT) is expected to report earnings for its fourth quarter. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Sana Biotechnology (NASDAQ:SANA) shares moved upwards by 9.1% to $6.1 during Friday's after-market session. The company's market cap stands at $1.1 billion. 
Via Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Hims & Hers Health (NYSE:HIMS)... 
Via Benzinga
Why Shares of Immunovant Are Down Almost 10% This Afternoon
An analyst note is extending yesterday's sell-off. 
Via The Motley Fool
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2021
Upgrades For SolarEdge Technologies Inc (NASDAQ: 
Via Benzinga
Why Shares of Immunovant Are Tanking Today
Shareholders are throwing in the towel after not getting the deal they were expecting. 
Via The Motley Fool
Mid-Afternoon Market Update: Nasdaq Gains 50 Points; Marin Software Shares Plummet
Toward the end of trading Monday, the Dow traded up 0.02% to 34,941.69 while the NASDAQ rose 0.37% to 14,727.42. The S&P also rose, gaining 0.10% to 4,399.45. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands (NYSE:LVS) was the largest firm by market cap to set a new 52-... 
Via Benzinga
Immunovant Stock Plunges After Credit Suisse Downgrade Citing Unclear Catalysts
Credit Suisse downgraded Immunovant Inc (NASDAQ: 
Via Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program.... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock increased by 35.01% to $5.5 during Monday's regular session. Trading volume for Xenetic Biosciences's stock is 10.1... 
Via Benzinga
Mid-Day Market Update: Crude Oil Down 2.5%; Exicure Shares Spike Higher
Midway through trading Monday, the Dow traded up 0.35% to 35,058.26 while the NASDAQ rose 0.52% to 14,748.83. The S&P also rose, gaining 0.39% to 4,412.29. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
40 Stocks Moving In Monday's Mid-Day Session
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 133% to $5.27 after the company announced a $5 million stock repurchase program. Exicure, Inc. (NASDAQ:... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Global Payments Posts Upbeat Q2 Earnings
Following the market opening Monday, the Dow traded up 0.58% to 35,138.90 while the NASDAQ rose 0.40% to 14,731.03. The S&P also rose, gaining 0.46% to 4,415.36. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks That Hit 52-Week Lows On Monday
Monday morning, 34 companies reached new 52-week lows. Things to Consider: Las Vegas Sands (NYSE:LVS) was the largest, in terms of market cap, to set a new 52-week... 
Via Benzinga
Immunovant Stock Plunges On $200M Equity Investment From Roivant To Support IMVT-1401 Development
Immunovant Inc (NASDAQ: IMVT) has received a $200 million strategic investment from Roivant Sciences that the Company will use to advance IMVT-1401 in... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Exicure (NASDAQ:XCUR) stock moved upwards by 35.55% to $1.83 during Monday's pre-market session. The company's market cap stands at $161.0 million.... 
Via Benzinga
Biotech Losers In 2021 That Could Bounce Big In The Second Half
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. Here's a list of biotech stocks that were among the worst performers in the first half but have the potential to... 
Via Talk Markets
Biotech Losers In 2021 That Could Bounce Big In The Second Half
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.